DrugBiological
Izokibep clinical trials
Also written ABY-035.
- studies test it
- 10
- open now
- 0
- in phase 3
- 2
- first study started
- 2016
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2022 (4)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 7
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 10 · Other 0
Studies
Open first, then newest update. How each study uses izokibep is read from its arms, and is right about nine times in ten.
Testing it · 10
- Hidradenitis Suppurativa Study of IzokibepTerminatedPhase 3ACELYRIN Inc.NCT05905783Written as Izokibep
- Hidradenitis Suppurativa Phase 2b Study of IzokibepCompletedPhase 2ACELYRIN Inc.NCT05355805Written as Izokibep
- Psoriatic Arthritis Study of IzokibepTerminatedPhase 2/3ACELYRIN Inc.NCT05623345Written as Izokibep
- Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitisTerminatedPhase 2ACELYRIN Inc.NCT05384249Written as Izokibep
- A Trial of the Efficacy and Safety of Izokibep in the Treatment of Non-anterior UveitisCompletedPhase 2ACELYRIN Inc.NCT04706741Written as Izokibep
- A Study to Investigate Efficacy, Tolerability and Safety of ABY-035 in Patients With Active Psoriatic ArthritisCompletedPhase 2ACELYRIN Inc.NCT04713072Written as ABY-035
- ABY-035 in the Treatment of Subjects With Ankylosing SpondylitisTerminatedPhase 2Inmagene LLCNCT04795141Written as ABY-035
- A Study to Evaluate ABY-035 in Subjects With Moderate-to-severe Plaque PsoriasisCompletedPhase 2AffibodyNCT03591887Written as ABY-035
- A Study to Investigate the Safety, Tolerability, Pharmacokinetic, and Efficacy of ABY-035/AFO2CompletedPhase 1AffibodyNCT03580278Written as ABY-035/AFO2
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of ABY-035CompletedPhase 1AffibodyNCT02690142Written as ABY-035 i.v.
Codes
What other systems call izokibep · ClinicalTrials.gg INT015636
- UNII (FDA) 8B8VV1W6FZIZOKIBEPOne source FDA
- NCI Thesaurus C175101IzokibepOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 8B8VV1W6FZ | IZOKIBEP | One source FDA |
| NCI Thesaurus | C175101 | Izokibep | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.